3. Results
death
KIDNEY DISEASE
Twenty-two patients at Kidney Disease Outcomes Quality Initiative stage V undergoing maintenance hemodialysis were proposed to participate in the study between September 2021 and June 2022 at the Unit of Nephrology and Dialysis of University Hospital of Ferrara. Eleven patients were randomised into the RMT group, whereas the remaining 11 acted as the CON group (C). At baseline, the patients did not differ for any demographic or clinical characteristics, or for any outcome measure (Three patients dropped out early from the trial due to death or hospitalisation or for kidney transplantation (